These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 28991715)

  • 1. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
    Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
    J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
    Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
    J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transthyretin Amyloid Neuropathy: The Schwann Cell Hypothesis.
    Murakami T; Sunada Y
    Adv Exp Med Biol; 2019; 1190():371-378. PubMed ID: 31760657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of dorsal root ganglion in a pre-symptomatic subject with familial amyloid polyneuropathy transthyretin E61K.
    Murakami T; Watanabe H; Yamamoto A; Sunada Y
    J Neurol Sci; 2022 Sep; 440():120329. PubMed ID: 35777313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.
    Nagasaka T; Togashi S; Watanabe H; Iida H; Nagasaka K; Nakamura Y; Miwa M; Kobayashi F; Shindo K; Shiozawa Z
    J Neurol Sci; 2009 Jan; 276(1-2):88-94. PubMed ID: 18930252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transthyretin familial amyloid polyneuropathy].
    Kopishinskaya SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):82-89. PubMed ID: 30499502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
    Sousa MM; Saraiva MJ
    Prog Neurobiol; 2003 Dec; 71(5):385-400. PubMed ID: 14757117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
    Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
    Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients.
    Cappellari M; Cavallaro T; Ferrarini M; Cabrini I; Taioli F; Ferrari S; Merlini G; Obici L; Briani C; Fabrizi GM
    J Peripher Nerv Syst; 2011 Jun; 16(2):119-29. PubMed ID: 21692911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
    Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH
    Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.
    Schmidt HH; Barroso F; González-Duarte A; Conceição I; Obici L; Keohane D; Amass L
    Muscle Nerve; 2016 Sep; 54(3):353-60. PubMed ID: 27273296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy.
    Leibou L; Frand J; Sadeh M; Lossos A; Kremer E; Livneh A; Yarnitsky D; Herman O; Dabby R
    Isr Med Assoc J; 2012 Nov; 14(11):662-5. PubMed ID: 23240369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
    Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
    Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid polyneuropathy due to transthyretin Ala97Ser.
    Kan HW; Chiang H; Lin WM; Yu IS; Lin SW; Hsieh ST
    Neuropathol Appl Neurobiol; 2018 Dec; 44(7):673-686. PubMed ID: 29423915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
    Ebenezer GJ; Liu Y; Judge DP; Cunningham K; Truelove S; Carter ND; Sebastian B; Byrnes K; Polydefkis M
    Ann Neurol; 2017 Jul; 82(1):44-56. PubMed ID: 28598015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
    Planté-Bordeneuve V; Ferreira A; Lalu T; Zaros C; Lacroix C; Adams D; Said G
    Neurology; 2007 Aug; 69(7):693-8. PubMed ID: 17698792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy.
    Koike H; Misu K; Sugiura M; Iijima M; Mori K; Yamamoto M; Hattori N; Mukai E; Ando Y; Ikeda S; Sobue G
    Neurology; 2004 Jul; 63(1):129-38. PubMed ID: 15249622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial amyloidotic polyneuropathy and transthyretin.
    Nagasaka T
    Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amyloid neuropathy].
    Ikegawa S
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1371-3. PubMed ID: 1966018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transthyretin familial amyloid polyneuropathy.
    Planté-Bordeneuve V; Kerschen P
    Handb Clin Neurol; 2013; 115():643-58. PubMed ID: 23931808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.